Neuropace Inc (NPCE)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Neuropace Inc-Aktie (NPCE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	4.42% 23.52	22.52	21.47	21.06	19.26
Cost Of Revenue	3.98% 5.388	5.182	5.278	5.64	5.122
Gross Profit	4.56% 18.13	17.34	16.19	15.42	14.13
Operating Expenses	10.97% 24.96	22.49	19.84	19.66	20.36
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	9.66% 30.34	27.67	25.12	25.30	25.49
Operating Income/Loss	32.58% -6.824	-5.147	-3.653	-4.243	-6.23
Income/Loss From Continuing Operations Before Tax	456.96% 23.52	-6.589	21.47	21.06	-7.514
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	31.29% -8.651	-6.589	-5.25	-5.452	-7.514
Net Income/Loss	31.29% -8.651	-6.589	-5.25	-5.452	-7.514
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	4.39% 32.86	31.48	0.2632	29.44	28.85
Diluted Average Shares	4.39% 32.86	31.48	0.2632	29.44	28.85
Basic Earnings Per Share	23.81% -0.26	-0.21	-0.17	-0.19	-0.26
Diluted Earnings Per Share	23.81% -0.26	-0.21	-0.17	-0.19	-0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

PODD

$318.77

1.84%

STE

$237.32

0.69%

DXCM

$60.43

3.80%

PHG

$27.21

0.40%

GEHC

$74.47

0.64%

$83.07

0.75%